Association of functional variants in the dopamine D2-like receptors with risk for gambling behaviour in healthy Caucasian subjects

Biological Psychology

Volumn 85, Issue 1, 2010, Pages 33-37

  Lobo, Daniela S S ^a,b   Souza, Renan P ^a,b   Tong, Ryan P ^a,b   Casey, David M ^c   Hodgins, David C ^c   Smith, Garry J ^d   Williams, Rob J ^e   Schopflocher, Don P ^d   Wood, Rob T ^e   el Guebaly, Nady ^c   Kennedy, James L ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Association study; Canadian Problem Gambling Index; CPGI; Dopaminergic signalling; DRD1; DRD2; DRD3; Genetics; Haplotype; Pathological gambling

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR;

ADULT; AGE DISTRIBUTION; ARTICLE; CAUCASIAN; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MALE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 77955281349     PISSN: 03010511     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2010.04.008     Document Type: Article

References (44)

1. A.P.A. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, (DSM-IV). 4th ed.
2. Allison D.B., Neale M.C., Zannolli R., et al. Testing the robustness of the likelihood-ratio test in a variance-component quantitative-trait loci-mapping procedure. American Journal of Human Genetics 1999, 65:531-544.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
4. Blanco C., Moreyra P., Nunes E.V., Saiz-Ruiz J., Ibanez A. Pathological gambling: addiction or compulsion?. Seminars in Clinical Neuropsychiatry 2001, 6:167-176.
5. Braverman J., Shaffer H.J. How do gamblers start gambling: identifying behavioural markers for high-risk internet gambling. European Journal of Public Health 2010.
6. Comings D.E., Gade R., Wu S., et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Molecular Psychiatry 1997, 2:44-56.
7. Comings D.E., Rosenthal R.J., Lesieur H.R., et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996, 6:223-234.
8. da Silva Lobo D.S., Vallada H.P., Knight J., et al. Dopamine genes and pathological gambling in discordant sib-pairs. Journal of Gambling Studies 2007, 23:421-433.
9. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genetic Epidemiology 2003, 25:115-121.
10. Durrant C., Zondervan K.T., Cardon L.R., et al. Linkage disequilibrium mapping via cladistic analysis of single-nucleotide polymorphism haplotypes. American Journal of Human Genetics 2004, 75:35-43.
11. Eisen S.A., Lin N., Lyons M.J., et al. Familial influences on gambling behavior: an analysis of 3359 twin pairs. Addiction 1998, 93:1375-1384.
12. Eisen S.A., Slutske W.S., Lyons M.J., et al. The genetics of pathological gambling. Seminars in Clinical Neuropsychiatry 2001, 6:195-204.
13. El-Guebaly N., Casey D.M., Hodgins D.C., et al. Designing a longitudinal cohort study of gambling in Alberta: rationale, methods, and challenges. Journal of Gambling Studies 2008, 24:479-504.
14. Ferris J., Wynne H. The Canadian problem gambling index: final report. Canadian Centre on Substance Abuse 2001.
15. Gelernter J., Yu Y., Weiss R., et al. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Human Molecular Genetics 2006, 15:3498-3507.
16. Hirvonen M.M., Laakso A., Nagren K., et al. C957T polymorphism of dopamine D2 receptor gene affects striatal DRD2 in vivo availability by changing the receptor affinity. Synapse 2009, 63:907-912.
17. Hirvonen M.M., Lumme V., Hirvonen J., et al. C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Progress in Neuropsychopharmacology and Psychiatry 2009, 33:630-636.
18. Huang W., Payne T.J., Ma J.Z., et al. Significant association of ANKK1 and detection of a functional polymorphism with nicotine dependence in an African-American Sample. Neuropsychopharmacology 2008.
19. Jeanneteau F., Funalot B., Jankovic J., et al. A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:10753-10758.
20. Jonsson E.G., Nothen M.M., Grunhage F., et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry 1999, 4:290-296.
21. Karkowski L.M., Prescott C.A., Kendler K.S. Multivariate assessment of factors influencing illicit substance use in twins from female-female pairs. American Journal of Medical Genetics 2000, 96:665-670.
22. Kelley A.E. Functional specificity of ventral striatal compartments in appetitive behaviors. Annals of the New York Academy of Sciences 1999, 877:71-90.
23. Kendler K.S., Jacobson K.C., Prescott C.A., Neale M.C. Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. The American Journal of Psychiatry 2003, 160:687-695.
24. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
25. Lahiri D.K., Nurnberger J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Research 1991, 19:5444.
26. LaPlante D.A., Nelson S.E., LaBrie R.A., Shaffer H.J. Stability and progression of disordered gambling: lessons from longitudinal studies. Canadian Journal of Psychiatry 2008, 53:52-60.
27. Little J., Higgins J.P., Ioannidis J.P., et al. STrengthening the REporting of Genetic Association Studies (STREGA) - an extension of the STROBE statement. Genetic Epidemiology 2009, 33:581-598.
28. Lobo D.S., Kennedy J.L. Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities. Addiction 2009, 104:1454-1465.
29. Marco-Pallares J., Cucurell D., Cunillera T., et al. Genetic variability in the dopamine system (dopamine receptor D4, catechol-O-methyltransferase) modulates neurophysiological responses to gains and losses. Biological Psychiatry 2009, 66:154-161.
30. Neville M.J., Johnstone E.C., Walton R.T. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Human Mutation 2004, 23:540-545.
31. Noble E.P. Addiction and its reward process through polymorphisms of the D2 dopamine receptor gene: a review. European Psychiatry 2000, 15:79-89.
32. Pelchat M.L. Of human bondage: food craving, obsession, compulsion, and addiction. Physiology and Behavior 2002, 76:347-352.
33. Potkin S.G., Basile V.S., Jin Y., et al. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine. Molecular Psychiatry 2003, 8:109-113.
34. Radwan G.N., El-Setouhy M., Mohamed M.K., et al. DRD2/ANKK1 TaqI polymorphism and smoking behavior of Egyptian male cigarette smokers. Nicotine and Tobacco Research 2007, 9:1325-1329.
35. Riba J., Kramer U.M., Heldmann M., Richter S., Munte T.F. Dopamine agonist increases risk taking but blunts reward-related brain activity. PLoS One 2008, 3:e2479.
36. Robins L.N., Wing J., Wittchen H.-U., et al. The Composite International Diagnostic Interview: An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry 1989, 45:1069-1077.
37. Shaffer H.J., Hall M.N. Updating and refining prevalence estimates of disordered gambling behaviour in the United States and Canada. Canadian Journal of Public Health 2001, 92:168-172.
38. Shaffer H.J., Hall M.N., Vander Bilt J. Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. American Journal of Public Health 1999, 89:1369-1376.
39. Shaffer H.J., LaPlante D.A., LaBrie R.A., et al. Toward a syndrome model of addiction: multiple expressions, common etiology. Harvard Review of Psychiatry 2004, 12:367-374.
40. Slutske W.S., Eisen S., True W.R., et al. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Archives of General Psychiatry 2000, 57:666-673.
41. Tsuang M.T., Lyons M.J., Meyer J.M., et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Archives of General Psychiatry 1998, 55:967-972.
42. Volkow N.D., Li T.K. Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences. Pharmacology and Therapeutics 2005, 108:3-17.
43. Yang B.Z., Kranzler H.R., Zhao H., et al. Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. Alcoholism-Clinical and Experimental Research 2008, 32:2117-2127.
44. Young M., Stevens M. SOGS and CGPI: parallel comparison on a diverse population. Journal of Gambling Studies 2008, 24:337-356.